Coles, D., Ruto, E and Frewer, L.J
The HIF scheme, aims to create an alternative (Patent-2), to the existing Intellectual Property Rights (IPR) regime for rewarding pharmaceutical innovations through monopoly patents. Innovators would choose between the traditional IPR approach and the Patent-2 system to recoup innovation costs. Under Patent-2, reward would be based on the positive impact of the innovation on health globally. A two stage, international, expert stakeholder Delphi survey (N=25) was conducted to identify stakeholder requirements for acceptance and implementation of Patent-2. Broad stakeholder support for the scheme was identified. Some practical issues were identified which require resolution. A larger survey (N=84 international stakeholders) was used to validate these findings. Results broadly corroborated the conclusions of the Delphi survey.